Literature DB >> 9407044

Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation.

V Baldin1, C Cans, M Knibiehler, B Ducommun.   

Abstract

In eukaryotes the activity of CDK1 (CDC2), a cyclin-dependent kinase that initiates the structural changes that culminate in the segregation of chromosomes at mitosis, is regulated by the synergistic and opposing activities of a cascade of kinases and phosphatases. Dephosphorylation of threonine 14 and tyrosine 15 of CDK1 by the CDC25 phosphatases is a key step in the activation of the CDK1-cyclin B protein kinase. Little is currently known about the role and the regulation of CDC25B. Here we report in vitro and in vivo data that indicate that CDC25B is degraded by the proteasome. This degradation is dependent upon phosphorylation by the CDK1-cyclin A complex but not by CDK1-cyclin B. These results indicate that CDK1-cyclin A phosphorylation targets CDC25B for degradation and that this might be an important component of cell cycle regulation at the G2/M transition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407044     DOI: 10.1074/jbc.272.52.32731

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Cell cycle checkpoints and their inactivation in human cancer.

Authors:  M Molinari
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

2.  Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability.

Authors:  Niels Mailand; Alexandre V Podtelejnikov; Anja Groth; Matthias Mann; Jiri Bartek; Jiri Lukas
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

3.  Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway.

Authors:  Fei Chen; Zhuo Zhang; Jacquelyn Bower; Yongju Lu; Stephen S Leonard; Min Ding; Vince Castranova; Helen Piwnica-Worms; Xianglin Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

Review 4.  Proteasome-dependent degradation of human CDC25B phosphatase.

Authors:  C Cans; B Ducommun; V Baldin
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

5.  Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis.

Authors:  M Molinari; C Mercurio; J Dominguez; F Goubin; G F Draetta
Journal:  EMBO Rep       Date:  2000-07       Impact factor: 8.807

6.  Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases.

Authors:  Yoshinori Kanemori; Katsuhiro Uto; Noriyuki Sagata
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-21       Impact factor: 11.205

Review 7.  Proteasome inhibition: a new strategy in cancer treatment.

Authors:  J Adams; V J Palombella; P J Elliott
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

8.  Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest.

Authors:  X Wang; C H McGowan; M Zhao; L He; J S Downey; C Fearns; Y Wang; S Huang; J Han
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage.

Authors:  Béatrix Bugler; Estelle Schmitt; Bernadette Aressy; Bernard Ducommun
Journal:  Mol Cancer       Date:  2010-02-04       Impact factor: 27.401

10.  Phosphorylation of threonine 61 by cyclin a/Cdk1 triggers degradation of stem-loop binding protein at the end of S phase.

Authors:  M Murat Koseoglu; Lee M Graves; William F Marzluff
Journal:  Mol Cell Biol       Date:  2008-05-19       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.